Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1097/CCM.0000000000006298 | ||||
| Año | 2024 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
OBJECTIVES:To investigate the sleep and circadian health of critical survivors 12 months after hospital discharge and to evaluate a possible effect of the severity of the disease within this context. DESIGN:Observational, prospective study. SETTING:Single-center study. PATIENTS:Two hundred sixty patients admitted to the ICU due to severe acute respiratory syndrome coronavirus 2 infection. INTERVENTIONS:None. MEASUREMENTS AND MAIN RESULTS:The cohort was composed of 260 patients (69.2% males), with a median (quartile 1-quartile 3) age of 61.5 years (52.0-67.0 yr). The median length of ICU stay was 11.0 days (6.00-21.8 d), where 56.2% of the patients required invasive mechanical ventilation (IMV). The Pittsburgh Sleep Quality Index (PSQI) revealed that 43.1% of the cohort presented poor sleep quality 12 months after hospital discharge. Actigraphy data indicated an influence of the disease severity on the fragmentation of the circadian rest-activity rhythm at the 3- and 6-month follow-ups, which was no longer significant in the long term. Still, the length of the ICU stay and the duration of IMV predicted a higher fragmentation of the rhythm at the 12-month follow-up with effect sizes (95% CI) of 0.248 (0.078-0.418) and 0.182 (0.005-0.359), respectively. Relevant associations between the PSQI and the Hospital Anxiety and Depression Scale (rho = 0.55, anxiety; rho = 0.5, depression) as well as between the fragmentation of the rhythm and the diffusing lung capacity for carbon monoxide (rho = -0.35) were observed at this time point. CONCLUSIONS:Our findings reveal a great prevalence of critical survivors presenting poor sleep quality 12 months after hospital discharge. Actigraphy data indicated the persistence of circadian alterations and a possible impact of the disease severity on the fragmentation of the circadian rest-activity rhythm, which was attenuated at the 12-month follow-up. This altogether highlights the relevance of considering the sleep and circadian health of critical survivors in the long term.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Henriquez-Beltran, Mario | - |
Hosp Univ Arnau Vilanova Santa Maria - España
Universidad Adventista de Chile - Chile Hospital Universitari Arnau de Vilanova de Lleida - España |
| 2 | Vaca, Rafaela | Mujer |
Hosp Univ Arnau Vilanova Santa Maria - España
Inst Hlth Carlos III - España Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| 3 | Benitez, Ivan D. | Hombre |
Hosp Univ Arnau Vilanova Santa Maria - España
Inst Hlth Carlos III - España Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| 4 | Gonzalez, Jessica | Mujer |
Hosp Univ Arnau Vilanova Santa Maria - España
Inst Hlth Carlos III - España Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| 5 | Santisteve, Sally | Mujer |
Hosp Univ Arnau Vilanova Santa Maria - España
Hospital Universitari Arnau de Vilanova de Lleida - España |
| 6 | Aguila, Maria | - |
Hosp Univ Arnau Vilanova Santa Maria - España
Hospital Universitari Arnau de Vilanova de Lleida - España |
| 7 | Minguez, Olga | Mujer |
Hosp Univ Arnau Vilanova Santa Maria - España
Inst Hlth Carlos III - España Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| 8 | Moncusi-Moix, Anna | Mujer |
Hosp Univ Arnau Vilanova Santa Maria - España
Inst Hlth Carlos III - España Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| 9 | Gort-Paniello, Clara | Mujer |
Hosp Univ Arnau Vilanova Santa Maria - España
Inst Hlth Carlos III - España Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| 10 | Torres, Gerard | Hombre |
Hosp Univ Arnau Vilanova Santa Maria - España
Inst Hlth Carlos III - España Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| 11 | LABARCA-TRUCIOS, GONZALO PATRICIO | Hombre |
Universidad de Concepción - Chile
Harvard Med Sch - Estados Unidos Harvard Medical School - Estados Unidos |
| 12 | Caballero, Jesus | Hombre |
Hosp Arnau Vilanova - España
Hospital Universitari Arnau de Vilanova de Lleida - España |
| 13 | Barbera, Carme | Mujer |
Hosp Univ Santa Maria - España
Hospital Universitari Santa Maria - España |
| 14 | Torres, A. | Hombre |
Inst Hlth Carlos III - España
Univ Barcelona - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España Universitat de Barcelona - España |
| 15 | de Gonzalo-Calvo, David | Hombre |
Hosp Univ Arnau Vilanova Santa Maria - España
Inst Hlth Carlos III - España Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| 16 | Barbe, Ferran | Hombre |
Hosp Univ Arnau Vilanova Santa Maria - España
Inst Hlth Carlos III - España Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| 17 | Targa, Adriano | Hombre |
Hosp Univ Arnau Vilanova Santa Maria - España
Inst Hlth Carlos III - España Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| Fuente |
|---|
| Fondo Europeo de Desarrollo Regional |
| European Regional Development Fund |
| Instituto de Salud Carlos III |
| Agencia Nacional de Investigación y Desarrollo |
| National Research and Development Agency |
| COVID |
| European Social Fund Plus |
| Centro de Investigación Biomédica en Red de Enfermedades Respiratorias |
| Jane Mateu Foundation |
| Donation Program "estar preparados" (Union Espanola de Entidades Aseguradoras y Reaseguradoras) |
| Institució Catalana de Recerca I Estudis Avançats Academia program |
| Unión Española de Entidades Aseguradoras y Reaseguradoras |
| Agradecimiento |
|---|
| This study was supported by the Instituto de Salud Carlos III through the projects PI22/00216 and COV20/00110, co-funded by Fondo Europeo de Desarrollo Regional ("Una manera de hacer Europa"), Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias, Donation Program "estar preparados" (Union Espanola de Entidades Aseguradoras y Reaseguradoras), and Jane Mateu Foundation. |
| Dr. Labarca received support for article research from the National Research and Development Agency; he acknowledges receiving financial support from the Agencia Nacional de Investigaci\u00F3n y Desarrollo (COVID 1005), Chile. Drs. Targa and de Gonzalo-Calvo have received financial support from Instituto de Salud Carlos III (Miguel Servet 2023: CP23/00095 and Miguel Servet 2020: CP20/00041, respectively), co-funded by Fondo Social Europeo Plus. Dr. Barb\u00E9 is supported by the Instituci\u00F3 Catalana de Recerca I Estudis Avan\u00E7ats Academia program. The remaining authors have disclosed that they do not have any potential conflicts of interest. |
| Dr. Labarca received support for article research from the National Research and Development Agency; he acknowledges receiving financial support from the Agencia Nacional de Investigaci\u00F3n y Desarrollo (COVID 1005), Chile. Drs. Targa and de Gonzalo-Calvo have received financial support from Instituto de Salud Carlos III (Miguel Servet 2023: CP23/00095 and Miguel Servet 2020: CP20/00041, respectively), co-funded by Fondo Social Europeo Plus. Dr. Barb\u00E9 is supported by the Instituci\u00F3 Catalana de Recerca I Estudis Avan\u00E7ats Academia program. The remaining authors have disclosed that they do not have any potential conflicts of interest. |